224 related articles for article (PubMed ID: 12495364)
1. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
De Lima MS; Hotopf M
Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
[TBL] [Abstract][Full Text] [Related]
2. Drugs versus placebo for dysthymia.
Lima MS; Moncrieff J
Cochrane Database Syst Rev; 2000; (4):CD001130. PubMed ID: 11034701
[TBL] [Abstract][Full Text] [Related]
3. A comparison of drugs versus placebo for the treatment of dysthymia.
Lima MS; Moncrieff J
Cochrane Database Syst Rev; 2000; (2):CD001130. PubMed ID: 10796749
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis.
de Lima MS; Hotoph M; Wessely S
Psychol Med; 1999 Nov; 29(6):1273-89. PubMed ID: 10616934
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological therapy of dysthymia.
Lapierre YD
Acta Psychiatr Scand Suppl; 1994; 383():42-8. PubMed ID: 7942067
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
Versiani M
J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
[TBL] [Abstract][Full Text] [Related]
10. Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors by using general linear models.
Ballesteros J
J Clin Psychopharmacol; 2005 Apr; 25(2):127-31. PubMed ID: 15738743
[TBL] [Abstract][Full Text] [Related]
11. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
Haykal RF; Akiskal HS
J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
[TBL] [Abstract][Full Text] [Related]
12. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
Boyer P; Lecrubier Y; Stalla-Bourdillon A; Fleurot O
Neuropsychobiology; 1999; 39(1):25-32. PubMed ID: 9892856
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants versus placebo for panic disorder in adults.
Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine versus other types of pharmacotherapy for depression.
Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
[TBL] [Abstract][Full Text] [Related]
15. Antidepressants for insomnia in adults.
Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
[TBL] [Abstract][Full Text] [Related]
16. Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
Williams JW; Mulrow CD; Chiquette E; Noël PH; Aguilar C; Cornell J
Ann Intern Med; 2000 May; 132(9):743-56. PubMed ID: 10787370
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
20. Depressive subtypes and efficacy of antidepressive pharmacotherapy.
Ayuso-Gutiérrez JL
World J Biol Psychiatry; 2005; 6 Suppl 2():31-7. PubMed ID: 16166021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
